Marc Gauthier

ORCID: 0000-0001-5037-2804
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Immune Cell Function and Interaction
  • Chemokine receptors and signaling
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • Heme Oxygenase-1 and Carbon Monoxide
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • T-cell and B-cell Immunology
  • Metabolism and Genetic Disorders
  • Amino Acid Enzymes and Metabolism
  • Long-Term Effects of COVID-19
  • Dengue and Mosquito Control Research
  • Mitochondrial Function and Pathology
  • Science, Research, and Medicine
  • Eosinophilic Esophagitis
  • SARS-CoV-2 and COVID-19 Research
  • Single-cell and spatial transcriptomics
  • S100 Proteins and Annexins
  • COVID-19 and healthcare impacts
  • Criminal Justice and Corrections Analysis
  • Historical and Scientific Studies
  • Eosinophilic Disorders and Syndromes
  • Vitamin D Research Studies
  • Metalloenzymes and iron-sulfur proteins

University of Pittsburgh
2013-2025

University of Pittsburgh Medical Center
2017-2024

Centre Hospitalier Universitaire de Sherbrooke
2021

Pulmonary and Allergy Associates
2017-2021

Emory University
2020

Assistance Publique – Hôpitaux de Paris
2009

Hôpital Ambroise-Paré
2009

We previously showed that Th1/type 1 inflammation marked by increased IFN-γ levels in the airways can be appreciated 50% of patients with severe asthma, despite high dose corticosteroid (CS) treatment. hypothesized a downstream target IFN-γ, CXCL10, which recruits Th1 cells via cognate receptor CXCR3, is an important contributor to Th1high asthma and CS unresponsiveness. show CXCL10 mRNA closely associated IFNG BAL asthmatics also mice subjected model, both context high-dose The inability...

10.1172/jci.insight.94580 article EN JCI Insight 2017-07-05

Severe asthma (SA) is a significant problem both clinically and economically, given its poor response to corticosteroids (CS). We recently reported complex type 1-dominated (IFN-γ-dominated) immune in more than 50% of severe asthmatics despite high-dose CS treatment. Also, IFN-γ was found be critical for increased airway hyperreactivity (AHR) our model SA. The transcription factor IRF5 expressed M1 macrophages can induce Th1/Th17 cocultured human T cells. Here we show markedly higher...

10.1172/jci.insight.91019 article EN JCI Insight 2017-05-17

Aberrant immune response is a hallmark of asthma, with 5-10% patients suffering from severe disease exhibiting poor to standard treatment. A better understanding the responses contributing heterogeneity critical for improving asthma management. T cells are major players in orchestration both mild and disease, but it unclear whether specific cell subsets influence symptom duration. Here we show significant association airway CD8+ effector memory re-expressing CD45RA (TEMRAs), not CD45RO+ or...

10.1172/jci.insight.185061 article EN cc-by JCI Insight 2025-03-06

Carbon monoxide poisoning affects 50,000 per year in the United States alone. Mortality is approximately 3%, and up to 40% of survivors suffer from permanent neurocognitive affective deficits. Hyperbaric oxygen therapy has shown benefit on reducing long-term neurologic sequelae carbon but not demonstrated improved survival. The objective this study assess efficacy hyperbaric for acute mortality using a large clinical databank.Retrospective analysis.University Pittsburgh Medical Center...

10.1097/ccm.0000000000003135 article EN Critical Care Medicine 2018-04-08
Abhaya Trivedi Chase Hall Charles W. Goss Daphne Lew James G. Krings and 95 more Mary Clare McGregor M. Samant Jered Sieren Huashi Li Ken B. Schechtman Joshua Schirm Stephen McEleney S. Peterson Wendy C. Moore Eugene R. Bleecker Deborah A. Meyers Elliot Israel George R. Washko Bruce D. Levy Joseph K. Leader Sally E. Wenzel John V. Fahy Mark L. Schiebler Sean B. Fain Nizar N. Jarjour David T. Mauger Joseph M. Reinhardt John D. Newell Eric A. Hoffman Mario Castro Ajay Sheshadri Elliot Israel Bruce D. Levy Manuela Cernadas George R. Washko Kathleen J. Haley Juan Carlos Cardet Melody G. Duvall Victoria E. Forth Meghan Le Eva Fandozzi Allison F. O’Neill Katarina Gentile Maria Cinelli Abigail Tulchinsky Guilberto Lawrance Randall Czajkowski Peter Lemole William Antunes Ann D. McGinnis Kris Klokeid Wanda Phipatanakul William J. Sheehan Lisa Bartnikas Sachin N. Baxi Elena Crestani Brittany Etsy Jonathan M. Gaffin Marissa Hauptman David Kantor Peggy S. Lai Margee Louisias Kyle A. Nelson Perdita Permaul Lynda C. Schneider Lakiea S. Wright Samantha Minnicozzi Michelle C. Maciag Mehtap Haktanir-Abul Sigfus Gunnlaugsson Elizabeth Burke‐Roberts Amparito Cunningham Ethan Ansel-Kelly Sullivan Waskosky Anna Ramsey Laura Feloney Sally E. Wenzel Merritt L. Fajt Juan C. Celedón Allyson Larkin Y. Peter Di Hong Wei Chu Marc Gauthier Wei Wu S. Jain Matthew Camiolo Christine Rauscher Faith S. Luyster Paul Rebovich Jessa Demas Renee Wunderley Catherine A. Vitari Melissa Ilnicki Diane Srollo Crystal Takosky Rose Lanzo Joseph K. Leader Daniel M. Lapic Emily Etling Donna H. Rhodes

Background Clustering key clinical characteristics of participants in the Severe Asthma Research Program (SARP), a large, multicenter prospective observational study patients with asthma and healthy controls, has led to identification novel phenotypes. Purpose To determine whether quantitative CT (qCT) could help distinguish between Materials Methods A retrospective cross-sectional analysis was conducted use qCT images (maximal bronchodilation at total lung capacity [TLC], or inspiration,...

10.1148/radiol.210363 article EN Radiology 2022-04-26

Rationale: Corticosteroid-responsive type 2 (T2) inflammation underlies the T2-high asthma endotype. However, we hypothesized that 1 (T1) inflammation, possibly related to viral infection, may also influence corticosteroid response. Objectives: To determine frequency and within-patient variability of T1-high, T2-high, T1/T2-high endotypes whether virally influenced T1-high disease influences response in asthma. Methods: Patients SARP-3 (Severe Asthma Research Program-3) had sputum collected...

10.1164/rccm.202402-0403oc article EN American Journal of Respiratory and Critical Care Medicine 2024-11-27

Section:ChooseTop of pageAbstract <<ProductivityMentorshipCareer DevelopmentResearch Funding Transiti...Effect on Academic Center...Personal WellnessWomen and Underrepresente...ConclusionsReferencesCITING ARTICLES

10.34197/ats-scholar.2020-0104ps article EN cc-by-nc-nd ATS Scholar 2020-09-21

Introduction Acute mortality from carbon monoxide poisoning is 1–3%. The long-term risk of survivors doubled compared to age-matched controls. Cardiac involvement also increases risk. We built a clinical score identify monoxide-poisoned patients at for acute and mortality.Methods performed retrospective analysis. identified 811 adult in the derivation cohort, 462 validation cohort. utilized baseline demographics, laboratory values, hospital charge transactions, discharge disposition,...

10.1080/15563650.2023.2226817 article EN Clinical Toxicology 2023-07-03

ABSTRACT The prevalence, inter-relationships, and longitudinal behavior of type 1 (T1) 2 (T2) immune responses in asthma are uncertain, as is the role viruses determinants these responses. Here, we performed whole transcriptome network analysis on sputum cells collected from Severe Asthma Research Program (SARP)-3 patients before after treatment with intramuscular corticosteroid again at 3-year follow-up visits. We used to analyze whole-transcriptome gene expression metagenomic RNA-seq data...

10.1101/2023.10.05.23296609 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-10-06
Coming Soon ...